The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia following head and neck cancer treatment.

Achieving well-defined shoulders requires a combination of targeted exercises that focus on different parts of the shoulder ...

Telix Pharmaceuticals Limited today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan[1]) in recurrent high-grade glioma (brain cancer), substantiating the ...